7.4 Paediatric Respiratory Infection and Immunology 2015
DOI: 10.1183/13993003.congress-2015.oa1989
|View full text |Cite
|
Sign up to set email alerts
|

Effect of recombinant α2-β-interferon therapy on virologic and immunologic characteristics by children at early age with acute respiratory viral infections

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2016
2016
2018
2018

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Hence the results should not be extrapolated to the concept that any infant with saturations >90% early in the course of the illness can be safely discharged. A Russian group presented data suggesting that the use of recombinant α2-interferon administered once daily to children aged <3 years admitted with respiratory viral infections resulted in more rapid resolution of inflammation and clearance of virus [ 96 ].…”
Section: Infection and Immunitymentioning
confidence: 99%
“…Hence the results should not be extrapolated to the concept that any infant with saturations >90% early in the course of the illness can be safely discharged. A Russian group presented data suggesting that the use of recombinant α2-interferon administered once daily to children aged <3 years admitted with respiratory viral infections resulted in more rapid resolution of inflammation and clearance of virus [ 96 ].…”
Section: Infection and Immunitymentioning
confidence: 99%